Ligand Pharmaceuticals vs Teleflex

Ligand Pharmaceuticals (LGND), health care, and Teleflex (TFX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Teleflex is worth $6.3B on the stock market and Ligand Pharmaceuticals $5.9B: Teleflex is valued at 8% more. Ligand Pharmaceuticals trades at 118 times earnings and Teleflex at 78.6; operating margins in their latest fiscal years were 15.3% and 5.94%. Over the past year Ligand Pharmaceuticals's share price has moved +45.7% and Teleflex's +46.2%.

Key facts

Ligand Pharmaceuticals market value
$5.9B
Teleflex market value
$6.3B
Ligand Pharmaceuticals P/E
118
Teleflex P/E
78.6
Ligand Pharmaceuticals revenue
$268.1MFY to 2025-12-31
Teleflex revenue
$2BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Ligand Pharmaceuticals vs Teleflex: every measure side by side
Measure Ligand Pharmaceuticals Teleflex
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$5.9Blower$6.3Bhigher
Revenue$268.1Mlower$2Bhigher
Earnings$124.5Mhigher-$905.6Mlower
Employees47lower15,500higher
Total assets$1.6Blower$6.9Bhigher
Valuation
P/E118higher78.6lower
P/S21.9higher3.2lower
P/B6.1higher1.8lower
Dividend yield0.00%lower0.87%higher
Profitability
Operating margin15.3%higher5.94%lower
Balance sheet
Net assets$1Blower$3.1Bhigher
Total liabilities$543.4Mlower$3.8Bhigher
Total debt—$2.6B
Cash on hand$174.9Mlower$378.6Mhigher
Price change
Today-2.62%lower+1.56%higher
1 year+45.7%lower+46.2%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Ligand Pharmaceuticals only (0)

None of the tracked investors.

Percentages are each holding's share of that investor's reported portfolio. · Who owns TFX

Further comparisons

Learn

Questions and answers

Which is bigger, Ligand Pharmaceuticals or Teleflex?

By market value, Teleflex is the larger: $6.3B against $5.9B for Ligand Pharmaceuticals. By revenue in its latest fiscal year, Teleflex is the larger: $2B against $268.1M for Ligand Pharmaceuticals.

Which has the higher P/E ratio?

Ligand Pharmaceuticals: 118, against 78.6 for Teleflex. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Ligand Pharmaceuticals: 15.3%, against 5.94% for Teleflex. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Teleflex: 0.87%, against 0.00% for Ligand Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Ligand Pharmaceuticals and Teleflex?

None of the tracked superinvestors holds both in their latest 13F filing. 0 hold Ligand Pharmaceuticals and 4 hold Teleflex.

Cite this page

Funkfolio, “Ligand Pharmaceuticals vs Teleflex”, data as of 18 November 2026. https://funkfolio.com/compare/lgnd-vs-tfx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.